O
ORGANOGENESIS HOLDINGS INC
NASDAQ: ORGO (Organogenesis Holdings Inc.)
最近更新时间: 11小时之前3.10
0.07 (2.31%)
| 前收盘价格 | 3.03 |
| 收盘价格 | 3.03 |
| 成交量 | 306,691 |
| 平均成交量 (3个月) | 716,241 |
| 市值 | 389,750,592 |
| 价格/销量 (P/S) | 0.930 |
| 股市价格/股市净资产 (P/B) | 1.52 |
| 52周波幅 | |
| 利润日期 | 26 Feb 2025 - 3 Mar 2025 |
| 营业毛利率 | -1.62% |
| 营业利益率 (TTM) | 5.42% |
| 稀释每股收益 (EPS TTM) | -0.050 |
| 季度收入增长率 (YOY) | 6.10% |
| 季度盈利增长率 (YOY) | 289.40% |
| 总债务/股东权益 (D/E MRQ) | 38.65% |
| 流动比率 (MRQ) | 3.09 |
| 营业现金流 (OCF TTM) | 13.88 M |
| 杠杆自由现金流 (LFCF TTM) | 13.47 M |
| 资产报酬率 (ROA TTM) | 1.64% |
| 股东权益报酬率 (ROE TTM) | -2.66% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Organogenesis Holdings Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-0.8
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.83 |
|
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 46.36% |
| 机构持股比例 | 50.88% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Soleus Capital Management, L.P. | 30 Sep 2024 | 11,839,876 |
| Aqr Capital Management Llc | 30 Sep 2024 | 2,710,606 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合